These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

848 related items for PubMed ID: 15337828

  • 1. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells.
    Shah S, Sylvester PW.
    Exp Biol Med (Maywood); 2004 Sep; 229(8):745-55. PubMed ID: 15337828
    [Abstract] [Full Text] [Related]

  • 2. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW, Shah S.
    Asia Pac J Clin Nutr; 2005 Sep; 14(4):366-73. PubMed ID: 16326643
    [Abstract] [Full Text] [Related]

  • 3. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells.
    Sylvester PW, Shah SJ, Samant GV.
    J Plant Physiol; 2005 Jul; 162(7):803-10. PubMed ID: 16008108
    [Abstract] [Full Text] [Related]

  • 4. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
    Samant GV, Sylvester PW.
    Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
    [Abstract] [Full Text] [Related]

  • 5. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity.
    Shah SJ, Sylvester PW.
    Exp Biol Med (Maywood); 2005 Apr; 230(4):235-41. PubMed ID: 15792944
    [Abstract] [Full Text] [Related]

  • 6. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D, Mauri D, Peters N, Juo P, Thome M, Reichwein M, Blenis J, Scheurich P, Tschopp J, Wajant H.
    J Biol Chem; 2001 Aug 31; 276(35):32585-90. PubMed ID: 11384965
    [Abstract] [Full Text] [Related]

  • 7. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
    Rokhlin OW, Guseva NV, Tagiyev AF, Glover RA, Cohen MB.
    Prostate; 2002 Jun 01; 52(1):1-11. PubMed ID: 11992615
    [Abstract] [Full Text] [Related]

  • 8. Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells.
    Shah S, Gapor A, Sylvester PW.
    Nutr Cancer; 2003 Jun 01; 45(2):236-46. PubMed ID: 12881019
    [Abstract] [Full Text] [Related]

  • 9. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation.
    Kang YC, Kim KM, Lee KS, Namkoong S, Lee SJ, Han JA, Jeoung D, Ha KS, Kwon YG, Kim YM.
    Cell Death Differ; 2004 Dec 01; 11(12):1287-98. PubMed ID: 15297884
    [Abstract] [Full Text] [Related]

  • 10. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
    Bachawal SV, Wali VB, Sylvester PW.
    BMC Cancer; 2010 Mar 08; 10():84. PubMed ID: 20211018
    [Abstract] [Full Text] [Related]

  • 11. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 12. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells.
    Panka DJ, Mano T, Suhara T, Walsh K, Mier JW.
    J Biol Chem; 2001 Mar 09; 276(10):6893-6. PubMed ID: 11145953
    [Abstract] [Full Text] [Related]

  • 13. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH, Bellail A, Tse MC, Yong VW, Hao C.
    J Neurosci; 2006 Mar 22; 26(12):3299-308. PubMed ID: 16554480
    [Abstract] [Full Text] [Related]

  • 14. Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.
    Milani D, Zauli G, Rimondi E, Celeghini C, Marmiroli S, Narducci P, Capitani S, Secchiero P.
    J Neurochem; 2003 Jul 22; 86(1):126-35. PubMed ID: 12807432
    [Abstract] [Full Text] [Related]

  • 15. Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway.
    Kim KM, Lee YJ.
    Oncogene; 2005 Jan 13; 24(3):355-66. PubMed ID: 15558024
    [Abstract] [Full Text] [Related]

  • 16. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.
    Oka N, Nakahara S, Takenaka Y, Fukumori T, Hogan V, Kanayama HO, Yanagawa T, Raz A.
    Cancer Res; 2005 Sep 01; 65(17):7546-53. PubMed ID: 16140916
    [Abstract] [Full Text] [Related]

  • 17. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway.
    Nam SY, Amoscato AA, Lee YJ.
    Oncogene; 2002 Jan 17; 21(3):337-46. PubMed ID: 11821946
    [Abstract] [Full Text] [Related]

  • 18. Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes.
    Uriarte SM, Joshi-Barve S, Song Z, Sahoo R, Gobejishvili L, Jala VR, Haribabu B, McClain C, Barve S.
    Cell Death Differ; 2005 Mar 17; 12(3):233-42. PubMed ID: 15665818
    [Abstract] [Full Text] [Related]

  • 19. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N, Poulaki V, Mitsiades C, Tsokos M.
    Cancer Res; 2001 Mar 15; 61(6):2704-12. PubMed ID: 11289151
    [Abstract] [Full Text] [Related]

  • 20. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
    Kim JH, Ajaz M, Lokshin A, Lee YJ.
    Clin Cancer Res; 2003 Aug 01; 9(8):3134-41. PubMed ID: 12912965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.